Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis submits second FDA application for CAR-T therapy Kymriah, this time in diffuse large B-cell lymphoma

October 31, 2017
Manufacturing and Production, Sales and Marketing CAR-T, Kymriah, Novartis

Following the “historic” FDA approval of the company’s CAR-T therapy Kymriah (tisagenlecleucel) in the treatment of paediatric and young adults …

News
amgen_hq

Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m

October 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Kirin, joint venture, pharma

Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …

News
janssen_latest_logo_on_sign_closer

Janssen’s Stelara shows improvement in Crohn’s symptoms within one week, new findings reveal

October 30, 2017
Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma

Janssen has unveiled new data on Stelara (ustekinumab) in the treatment of patients with moderately to severely active Crohn’s disease …

News

MSD withdraws European application of Keytruda combo in lung cancer

October 30, 2017
Sales and Marketing EMA, MSD, keytruda

MSD has been forced to withdraw its EU marketing application for Keytruda (pembrolizumab) in combination with pemetrexed and carboplatin as …

News
astrazeneca_sign_sky

AstraZeneca licenses genetic disease drug to Mereo Biopharma for $5 million, becomes shareholder

October 30, 2017
Sales and Marketing AstraZeneca, Mereo BioPharma, pharma

AstraZeneca has agreed to license AZD9668, its experimental drug for the treatment of alpha-1 antitrypsin deficiency, to Mereo Biopharma for …

News
novartis_window

Novartis to bolster oncology portfolio with $3.9 billion acquisition

October 30, 2017
Sales and Marketing Advanced Acclerator Applications, Lutathera, Novartis, pharma

Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce …

News
merckentranceweb

Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

October 30, 2017
Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …

News
pfizer-building-logo1web

Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says

October 30, 2017
Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …

News
online_survey_icon_or_logo

Collaboration in Biopharma

October 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague,

Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …

News
cyber-security-1923446_960_720

NHS was crippled by “unsophisticated” cyber attack

October 27, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% …

News
shutterstock_138095450

Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl

October 27, 2017
Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids

John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …

News
celgene_exteriors-3

Celgene hikes price of Revlimid to mask poor Q3 results

October 27, 2017
Medical Communications, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical

Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …

News
abbvieuse_054_low

AbbVie’s psoriasis drug smashes all endpoints

October 26, 2017
Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab

AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …

News
amber_hr_2

Is the NHS prepared for the upcoming winter season?

October 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …

Feature
gsk_wall

GSK eyes healthcare expansion, hits targets due to new drugs

October 26, 2017
Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical

During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …

News

Pfizer to begin auction of consumer health division next month

October 26, 2017
Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …

News
doctor-840127_960_720

NHS patients could be offered Airbnb-like accommodation

October 26, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting …

News
regeneron

Regeneron injects $100 million and 300 new roles into Irish production facility

October 26, 2017
Manufacturing and Production Regeneron, Sanofi, manufacturing, pharma

Sanofi subsidiary Regeneron has announced its intention to expand its production plant in Limerick, Ireland – the largest scale bulk …

News

Mental health problems cause 300,000 to leave work each year

October 26, 2017
Research and Development biotech, drugs, mental health, pharma, pharmaceutical

A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026